CB1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(2) Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astrogliaNeurobiology of diseaseOctober 1, 2019Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Pérez-Santiago J, Achim CL, et al.

(3) Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachmentToxicology and applied pharmacologyAugust 15, 2017Zhang Z, Yang C, Dai X, Ao Y, Li Y.

(4) (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motilityBiochemical pharmacologyFebruary 15, 2014Paul RK, Wnorowski A, Gonzalez-Mariscal I, Nayak SK, Pajak K, Moaddel R, Indig FE, Bernier M, Wainer IW.

(5) Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situThe Journal of allergy and clinical immunologyJuly 1, 2013Sugawara K, Zákány N, Hundt T, Emelianov V, Tsuruta D, Schäfer C, Kloepper JE, Bíró T, Paus R.

(7) Endocannabinoids limit excessive mast cell maturation and activation in human skinThe Journal of allergy and clinical immunologyMarch 1, 2012Sugawara K, Bíró T, Tsuruta D, Tóth BI, Kromminga A, Zákány N, Zimmer A, Funk W, Gibbs BF, Zimmer A, et al.

(8) AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin IIThe EMBO journalMay 3, 2011Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, Nieto N, Devi LA.

CB1 shRNA Plasmid (h)